Air pollution poses a significant environmental health risk, resulting in approximately 6.7 million premature deaths annually due to both ambient and household air pollution....
According to research by Duke University, immigrant mothers are increasingly worried about attending prenatal care appointments due to the possibility of a surprise ICE visit - seen in a significant decline in birthweight.
Professor Renata Riha, at the Edinburgh Department of Sleep Medicine, released new data about how coffee can balance short term cognitive impairment - as experienced by sleep deprived people, or shift pattern workers.
Israel has agreed to give the first 5,000 vaccine doses to Palestinian medical workers - but only if they live in annexed east Jerusalem, while the West Bank and Gaza remain without vaccines.
AstraZeneca dose efficiency holds at 76% in the three-month period between the first and second dose - suggesting that this time period is good for maximising protection.
Childhood air pollution has been understood as partially responsible for respiratory health - now, researchers are investigating at how exposure can damage cognitive ability later on in life.
According to data collected by 400 healthcare professionals at the worst moment of the US outbreak, the life support machine that acts in place of the heart and lungs is crucial to reducing COVID-19 deaths for the critically ill.
The American Heart Association found that young, Black adults are more than twice as likely to die in the first year after a heart transplant - in comparison to non-Black transplant recipients of the same age.
A professor describes severe maternal morbidity in low-income women as a public health crisis - now, Medicaid expansion seems to be improving pregnancy outcomes.
New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
Hugh Bettesworth, CEO, Mirada Medical, explores how AI autocontouring technology can help tackle the cancer care backlog as a result of the COVID-19 pandemic.
